News

The trial showed bioequivalence between the liquid and lyophilised formulations of caplacizumab. To date, the liquid formulation has been used in clinical trials but the lyophilised form is

As part of the deal, Illumina will provide its research use only Nextera Rapid Capture Enrichment kits and NGS technology to a multi-arm, early-stage National Lung Matrix Trial

The initial daclatasvir NDA submitted by the company to the FDA focused on the drug’s use in combination with asunaprevir, an NS3/4A protease inhibitor. Given the withdrawal of

FTC has also approved creation of a consumer healthcare joint venture (JV) by combining GSK’s Consumer Healthcare business and Novartis’ over-the-counter (OTC) Consumer Healthcare business. Novartis has agreed

The new vaccine candidate was co-developed by the National Institutes of Health’ (NIH) National Institute of Allergy and Infectious Diseases (NIAID) and Okairos, a biotechnology firm acquired by

Also known as Selincro, nalmefene is designed to be prescribed as a once-daily tablet to people who drink alcohol regularly. The drug helps those people who want to

The Hatfield production plant is operated by the company’s UK manufacturing subsidiary, Eisai Manufacturing. UK Minister for Life Sciences George Freeman said: "Pharmaceuticals manufacturing is important to our

Trulicity, a GLP-1 receptor agonist, is a once-weekly, injectable solution and it comes in a ready-to-use pen with a pre-attached, hidden needle. In September, Trulicity received a positive

Patient enrollment in the trial is being carried out at European oncology centers such as Radboud University Medical Center in the Netherlands), the Jules Bordet Institute in Belgium